Abiopharma

Financial Statements and Related Announcement: Full Yearly Results

FORM 6-K- Investor Presentation - June 2026

Martin Marietta to Combine with Lhoist North America in $13.5 Billion Transaction

Honeywell Aerospace completes spin-off from Honeywell Technologies and begins trading on Nasdaq

Keel Infrastructure Added to Russell 3000® Index

REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone

Compass Minerals Announces S&P Global Ratings Upgrade to B+

Gilat Receives $43 Million of Additional Sidewinder ESA Orders from Leading In-flight Connectivity Service Provider

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director - Chong Moi Me

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director / Chief Executive Officer - Ooi Shu Geok